Compounds > vanilmandelic acid
Page last updated: 2024-10-21

vanilmandelic acid and Dyslipidemias

vanilmandelic acid has been researched along with Dyslipidemias in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navarro, I1
Molina, M1
Civera, M1
Ascaso, JF1
Real, JT1
Carmena, R1

Reviews

1 review available for vanilmandelic acid and Dyslipidemias

ArticleYear
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:4

    Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamin

2011